Protalix BioTherapeutics (PLX) Payables (2010 - 2026)
Protalix BioTherapeutics' Payables came in at $6.51 million for Q2 2026, down 2.7% from $6.69 million a year earlier but up 51.8% from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Protalix BioTherapeutics' Payables was $5.26 million, up 16.0% from FY2024.
- Payables carries a five-year compound annual growth rate of -14.2% (FY2020 to FY2025).
- Going back by year, Payables was $4.53 million in FY2024 (+4.9%), $4.32 million in FY2023 (-26.3%), $5.86 million in FY2022 (-16.1%) and $6.99 million in FY2021 (-38.2%).
- The five-year range for quarterly Payables is $3.11 million (Q3 2023) to $8.44 million (Q3 2021).
- Year-over-year, Payables increased in seven of the last eight quarters, with growth averaging 23.7%.
- The fastest year-over-year change in Payables over five years came in Q3 2025 (growth of 71.5%), and the weakest in Q2 2023 (a decline of 52.7%).
- Business Quant data shows PLX's Payables at $4.29 million (Q1 2026), $5.26 million (Q4 2025) and $5.38 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.42 Bn | 1,106.00 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 617.98 Bn | 536.51 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 502.80 Bn | 475.92 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 368.67 Bn | 323.05 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 298.36 Bn | 262.35 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.17 Bn | 234.85 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.18 Bn | 192.58 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.11 Bn | 165.31 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 169.83 Bn | 116.48 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Protalix BioTherapeutics | 204.76 Mn | 53.38 Mn | 12.13 Mn | 6.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.51 Mn |
| Mar 31, 2026 | 4.29 Mn |
| Dec 31, 2025 | 5.26 Mn |
| Sep 30, 2025 | 5.38 Mn |
| Jun 30, 2025 | 6.69 Mn |
| Mar 31, 2025 | 4.12 Mn |
| Dec 31, 2024 | 4.53 Mn |
| Sep 30, 2024 | 3.14 Mn |
| Jun 30, 2024 | 4.06 Mn |
| Mar 31, 2024 | 3.15 Mn |
| Dec 31, 2023 | 4.32 Mn |
| Sep 30, 2023 | 3.11 Mn |
| Jun 30, 2023 | 3.30 Mn |
| Mar 31, 2023 | 5.11 Mn |
| Dec 31, 2022 | 5.86 Mn |
| Sep 30, 2022 | 5.64 Mn |
| Jun 30, 2022 | 6.99 Mn |
| Mar 31, 2022 | 7.87 Mn |
| Dec 31, 2021 | 6.99 Mn |
| Sep 30, 2021 | 8.44 Mn |
API Access
Protalix BioTherapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();